ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
INVO Bioscience, Inc. (INVO) stock declined over -2.00%, trading at $0.83 on NASDAQ, down from the previous close of $0.85. The stock opened at $0.86, fluctuating between $0.82 and $0.88 in the recent session.
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
Employees | 25 |
Beta | 1.44 |
Sales or Revenue | $3.02M |
5Y Sales Change% | 0.796% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |